Thus, Domenis et al. [71] investigated the immune modulatory properties of immunosuppressive ExVs secreted by tumor cells upon TLR4 activation when tumor cells escaped immune surveillance, so supporting tumor progression. The gene discussed is TLR4; the disease is neoplasm.